Barings LLC Has $516,000 Stake in Chemours Company (The) (CC)

Barings LLC maintained its stake in Chemours Company (The) (NYSE:CC) during the first quarter, Holdings Channel reports. The institutional investor owned 13,400 shares of the specialty chemicals company’s stock at the end of the first quarter. Barings LLC’s holdings in Chemours Company (The) were worth $516,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Ropes Wealth Advisors LLC boosted its stake in Chemours Company (The) by 82.4% in the first quarter. Ropes Wealth Advisors LLC now owns 3,099 shares of the specialty chemicals company’s stock valued at $119,000 after buying an additional 1,400 shares during the period. Schroder Investment Management Group acquired a new stake in Chemours Company (The) during the first quarter valued at approximately $156,000. Cypress Capital Management LLC WY boosted its stake in Chemours Company (The) by 1.9% in the first quarter. Cypress Capital Management LLC WY now owns 4,196 shares of the specialty chemicals company’s stock valued at $162,000 after buying an additional 80 shares during the period. Clean Yield Group acquired a new stake in Chemours Company (The) during the first quarter valued at approximately $167,000. Finally, United Capital Financial Advisers LLC acquired a new stake in Chemours Company (The) during the first quarter valued at approximately $203,000. Institutional investors own 75.01% of the company’s stock.

Chemours Company (CC) opened at 40.09 on Monday. Chemours Company has a 1-year low of $6.34 and a 1-year high of $46.02. The stock has a 50 day moving average price of $40.18 and a 200 day moving average price of $33.66. The firm has a market capitalization of $7.40 billion, a price-to-earnings ratio of 70.09 and a beta of 3.57.

Chemours Company (The) (NYSE:CC) last issued its earnings results on Monday, May 1st. The specialty chemicals company reported $0.75 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.25. Chemours Company (The) had a return on equity of 125.69% and a net margin of 1.91%. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.32 billion. During the same period in the prior year, the firm posted $0.06 EPS. The business’s revenue was up 10.8% compared to the same quarter last year. Analysts predict that Chemours Company will post $3.27 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, June 15th. Shareholders of record on Wednesday, May 17th were given a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.30%. The ex-dividend date was Monday, May 15th. Chemours Company (The)’s payout ratio is currently 22.22%.

COPYRIGHT VIOLATION WARNING: This news story was originally published by WKRB News and is owned by of WKRB News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.wkrb13.com/markets/2284951/barings-llc-has-516000-stake-in-chemours-company-the-cc.html.

Several analysts have commented on the company. Citigroup Inc. upgraded Chemours Company (The) from a “neutral” rating to a “buy” rating and lifted their price target for the company from $43.00 to $45.00 in a report on Wednesday, July 5th. Jefferies Group LLC raised Chemours Company (The) from a “hold” rating to a “buy” rating and lifted their price objective for the company from $35.00 to $48.00 in a research note on Wednesday, March 29th. J P Morgan Chase & Co raised Chemours Company (The) from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $39.00 to $50.00 in a research note on Friday, May 12th. BidaskClub lowered Chemours Company (The) from a “buy” rating to a “hold” rating in a research note on Saturday, June 17th. Finally, ValuEngine raised Chemours Company (The) from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $39.43.

In other news, insider Paul Kirsch sold 19,036 shares of the stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $41.42, for a total transaction of $788,471.12. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Richard H. Brown acquired 2,500 shares of the stock in a transaction dated Wednesday, May 3rd. The shares were bought at an average cost of $39.10 per share, for a total transaction of $97,750.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 46,725 shares of company stock worth $1,919,300. Insiders own 1.14% of the company’s stock.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Company (The) (NYSE:CC).

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284951/barings-llc-has-516000-stake-in-chemours-company-the-cc.html

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.